首页|成人先天性心脏病伴肺动脉高压患者介入术后严重不良事件风险预测模型构建及验证

成人先天性心脏病伴肺动脉高压患者介入术后严重不良事件风险预测模型构建及验证

扫码查看
目的 构建成人先天性心脏病(adult congenital heart disease,ACHD)合并肺动脉高压(pulmonary hypertension,PH)患者心导管介入术后严重不良事件(serious adverse event,SAE)风险预测评分模型,并验证其预测效果.方法 回顾性纳入2018年1月-2022年1月于武汉科技大学附属武汉市亚洲心脏病医院接受心导管介入术合并PH的ACHD患者.按照入院时间先后顺序将患者按照7∶3的比例随机分为模型组和验证组.模型组按介入术后是否发生SAE分为SAE组和非SAE组,对两组资料进行比较,根据多因素logistic回归分析结果建立风险预测模型.分别采用受试者工作特征(receiver operating characteristic,ROC)曲线下面积和Hosmer-Lemeshow检验对模型的区分度和校准度进行评价.结果 共纳入758例患者,其中男240例(31.7%)、女518例(68.3%),平均年龄43.1(18.0~81.0)岁.模型组530例(SAE组47例,非SAE组483例),验证组228例.单因素分析显示SAE组和非SAE组年龄、吸烟史、瓣膜病史、心力衰竭病史、N末端B型利钠肽原等差异有统计学意义(P<0.05).多因素分析显示年龄≥50岁、心力衰竭病史、中重度先天性心脏病、中重度PH、心导管介入检查并治疗、手术全身麻醉以及N末端B型利钠肽原≥126.65 pg/mL是ACHD-PH患者心导管介入术后SAE的危险因素(P<0.05).风险预测评分模型总分为0~139分,分值>50分为高危人群.模型验证结果显示ROC曲线下面积为0.937[95%CI(0.897,0.976)].Hosmer-Lemeshow 拟合优度检验:x2=3.847,P=0.797.结论 患者年龄≥ 50 岁、心力衰竭病史、中重度先天性心脏病、中重度PH、心导管介入检查并治疗、手术全身麻醉以及N末端B型利钠肽原≥ 126.65 pg/mL是ACHD-PH患者心导管介入术后发生SAE的危险因素.基于这些因素构建的风险预测模型具有较高的预测价值,可应用于ACHD-PH患者介入术后发生SAE的风险评估,以帮助临床医护人员进行早期干预.
Construction and validation of risk prediction model for serious adverse events in adult patients with congenital heart disease complicated with pulmonary hypertension after cardiac catheterization
Objective To construct a risk prediction score model for serious adverse event(SAE)after cardiac catheterization in patients with adult congenital heart disease(ACHD)and pulmonary hypertension(PH)and verify its predictive effect.Methods The patients with PH who underwent cardiac catheterization in Wuhan Asian Heart Hospital Affiliated to Wuhan University of Science and Technology from January 2018 to January 2022 were retrospectively collected.The patients were randomly divided into a model group and a validation group according to the order of admission.The model group was divided into a SAE group and a non-SAE group according to whether SAE occurred after the catheterization.The data of the two groups were compared,and the risk prediction score model was established according to the results of multivariate logistic regression analysis.The discrimination and calibration of the model were evaluated using the area under the receiver operating characteristic(ROC)curve and the Hosmer-Lemeshow test,respectively.Results A total of 758 patients were enrolled,including 240(31.7%)males and 518(68.3%)females,with a mean age of 43.1(18.0-81.0)years.There were 530 patients in the model group(47 patients in the SAE group and 483 patients in the non-SAE group)and 228 patients in the validation group.Univariate analysis showed statistical differences in age,smoking history,valvular disease history,heart failure history,N-terminal pro-B-type natriuretic peptide,and other factors between the SAE and non-SAE groups(P<0.05).Multivariate analysis showed that age≥ 50 years,history of heart failure,moderate to severe congenital heart disease,moderate to severe PH,cardiac catheterization and treatment,surgical general anesthesia,and N-terminal pro-B-type natriuretic peptide≥ 126.65 pg/mL were risk factors for SAE after cardiac catheterization for ACHD-PH patients(P<0.05).The risk prediction score model had a total score of 0-139 points and patients who had a score>50 points were high-risk patients.Model validation results showed an area under the ROC curve of 0.937(95% CI 0.897-0.976).Hosmer-Lemeshow goodness-of-fit test:x2=3.847,P=0.797.Conclusion Age≥50 years,history of heart failure,moderate to severe congenital heart disease,moderate to severe PH,cardiac catheterization and treatment,general anesthesia for surgery,and N-terminal pro-B-type natriuretic peptide≥ 126.65 pg/mL were risk factors for SAE after cardiac catheterization for ACHD-PH patients.The risk prediction model based on these factors has a high predictive value and can be applied to the risk assessment of SAE after interventional therapy in ACHD-PH patients to help clinicians perform early intervention.

Adult congenital heart diseasepulmonary hypertensioncatheterizationserious adverse eventrisk prediction model

胡娟舟、张迎红、张文、黄静、刘佳、彭盼

展开 >

武汉科技大学医学院(武汉 430065)

武汉科技大学附属武汉市亚洲心脏病医院心血管外科(武汉 430065)

武汉市普广医院心血管外科(武汉 430065)

成人先天性心脏病 肺动脉高压 介入术 严重不良事件 风险预测模型

湖北省健康委员会联合基金

WJ2019H345

2024

中国胸心血管外科临床杂志
四川大学华西医院

中国胸心血管外科临床杂志

CSTPCD北大核心
影响因子:0.846
ISSN:1007-4848
年,卷(期):2024.31(5)
  • 24